Diabetes therapy : research, treatment and education of diabetes and related disorders
Pros and Cons of Early Treatment with GLP-1 Receptor Agonist and SGLT-2 Inhibitors for Youth with Type 2 Diabetes: A Narrative Review.
Sean E DeLacey, Abigayil C Dieguez, Megan O Bensignor
Published: 202610.1007/s13300-025-01823-7
Abstract
The incidence of youth-onset type 2 diabetes (Y-T2D) has been increasing over the last two decades in line with the growing rate of childhood obesity. Prior to 2019, the only United States Food and Drug Administration (FDA)-approved therapies for Y-T…
Preview only. Read the full abstract at the source